MYLOTARG: payments to doctors
Payments that named MYLOTARG as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $275K
- Providers
- 840
- Transactions
- 1,502
- Average per transaction
- $183
The per-transaction average — $183 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 840 providers the average total is $327, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $247,957 | 90.2% |
| Laboratorios Pfizer LDA. | $24,535 | 8.9% |
| Whitehall International Inc | $2,500 | 0.9% |